Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -74.28 is 286% below its 4-year average of -19.24, near the low end of its 4-year range (-74.28–-9.15).
154.47% below its 12-month average of -29.19.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -8.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
EARNINGS PER SHARE (EPS)
-74.28
EARNINGS PER SHARE (EPS) AVG TTM
-29.19
EARNINGS PER SHARE (EPS) AVG 3Y
-19.57
EARNINGS PER SHARE (EPS) AVG 5Y
-19.24
EARNINGS PER SHARE (EPS) AVG 10Y
-29.13
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-154.47%
CURRENT VS 3Y AVG
-279.62%
CURRENT VS 5Y AVG
-286.17%
CURRENT VS 10Y AVG
-154.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Artelo Biosciences, Inc.
Market Cap
$1.39M
Earnings Per Share (EPS)
-74.28
TTM Avg
-29.19
3Y Avg
-19.57
5Y Avg
-19.24
Market Cap
$1.40M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.44
3Y Avg
-0.57
5Y Avg
-0.58
Market Cap
$1.35M
Earnings Per Share (EPS)
-158.78
TTM Avg
-3127.89
3Y Avg
-13218.44
5Y Avg
-15729.46
Market Cap
$1.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-14.23
3Y Avg
-10.02
5Y Avg
-9.01
Market Cap
$1.45M
Earnings Per Share (EPS)
-30.76
TTM Avg
-1622.27
3Y Avg
-9301.43
5Y Avg
-16503.78
Market Cap
$1.47M
Earnings Per Share (EPS)
-10.02
TTM Avg
-4.85
3Y Avg
-7.18
5Y Avg
-7.18
Market Cap
$1.47M
Earnings Per Share (EPS)
-14.22
TTM Avg
-74.60
3Y Avg
-142.80
5Y Avg
-169.23
Market Cap
$1.49M
Earnings Per Share (EPS)
-1815.30
TTM Avg
-34855.30
3Y Avg
-136953.83
5Y Avg
-91453.81
Market Cap
$1.18M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.39M | -74.28 | -29.19 | -19.57 | -19.24 |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | -0.71 | -0.44 | -0.57 | -0.58 |
| Genprex, Inc. (GNPX)vs › | $1.35M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
| NewcelX Ltd. (NCEL)vs › | $1.43M | N/A | -14.23 | -10.02 | -9.01 |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | -30.76 | -1622.27 | -9301.43 | -16503.78 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | -10.02 | -4.85 | -7.18 | -7.18 |
| Curis, Inc. (CRIS)vs › | $1.47M | -14.22 | -74.60 | -142.80 | -169.23 |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1815.30 | -34855.30 | -136953.83 | -91453.81 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | -19.33 | -12.55 | -11.71 | -15.69 |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | N/A | -76.17 | -936.34 | -837.30 |
Trailing EPS (TTM)
$-74.28
Forward EPS (Est.)
$-88.56
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -49.23 |
| 2024-12-31 | -9.15 |
| 2023-12-31 | -9.42 |
| 2022-12-31 | -10.47 |
| 2021-08-31 | -17.91 |
| 2020-08-31 | -56.48 |
| 2019-08-31 | -45.00 |
| 2018-08-31 | -82.55 |
| 2017-08-31 | -9.69 |
| 2016-08-31 | -1.41 |
| 2015-08-31 | -0.72 |
| 2014-08-31 | -1.80 |
